发明名称 P16<sup>INK4A </sup>derived peptides for prophylaxis and therapy of HPV-associated tumors and other P16<sup>INK4A </sup>expressing tumors
摘要 Described are particular fragments of the cyclin-dependent kinase inhibitor p16 capable of increasing IFN-γ secretion of T cells or inducing proliferation of T cells and the use of said fragments for immunizing an individual against HPV-associated or other p16INK4a expressing carcinomas, preferably advanced carcinomas.
申请公布号 US9114101(B2) 申请公布日期 2015.08.25
申请号 US201213714273 申请日期 2012.12.13
申请人 RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG 发明人 Kloor Matthias;Reuschenbach Miriam;Von Knebel-Doeberitz Magnus
分类号 C07K5/00;A61K39/00 主分类号 C07K5/00
代理机构 Perkins Coie LLP 代理人 Perkins Coie LLP ;Kung Viola T.
主权项 1. A fragment of the cyclin-dependent kinase inhibitor p16INK4 capable of inducing an immune response against p16INK4a, consisting of (a) any one of the following amino acid sequences:(SEQ ID NO: 3)(1) LPNAPNSYGRRPIQVMMMGSARVAELL; (SEQ ID NO: 4)(2) VMMMGSARVAELLLLHGAEPNCADPATLTR; (SEQ ID NO: 5)(3) ADPATLTRPVHDAAREGFLDTLVVLHRAGARL;  or (b) a combination of fragments of (a).
地址 Heidelberg DE
您可能感兴趣的专利